FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmacology, namely to drugs possessing diuretic and creatinuretic activity.
EFFECT: invention discloses the use of pinostrobin as a diuretic and creatinuretic agent, which enables to increase the effectiveness of the therapeutic effect and eliminate the occurrence of side effects.
7 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF DIHYDROQUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802874C1 |
| USE OF PINOCEMBRIN AS DIURETIC AND CREATININURETIC AGENT | 2023 |
|
RU2822937C1 |
| USE OF QUERCETIN AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802833C1 |
| USE OF HYPEROZIDE AS A DIURETIC, SALURETIC AND CREATININURETIC AGENT | 2022 |
|
RU2802832C1 |
| USE OF OREGANOL A WITH DIURETIC ACTIVITY | 2022 |
|
RU2802873C1 |
| USE OF PATULITRIN AS A DIURETIC | 2022 |
|
RU2807938C1 |
| DIURETIC | 2016 |
|
RU2619348C1 |
| DRUG PREPARATION POSSESSING DIURETIC ACTIVITY | 2011 |
|
RU2485966C1 |
| DIURETIC | 2016 |
|
RU2619346C1 |
| AGENT WITH DIURETIC ACTIVITY | 2016 |
|
RU2619349C1 |
